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Preface
Emerging Issues in Population Health:
National and Global Perspectives
A Tribute to Gene W. Matthews
Lawrence 0. Gostin, Guest Editor

Conference Center, across the street from the
Centers
for Disease
Control
Prevention
(CDC)
ne afternoon
in 1998
in theand
lobby
of the Emory
on Clifton Road in Atlanta, I sat on a leather sofa with one of
my oldest, dearest friends-Gene Matthews, Legal
Adviser to the CDC. Gene asked to meet me to talk about
how we might invigorate the field of public health law.
Matthews and his colleagues at CDC were hatching an idea
to commence a grass-roots movement in public health law.
The movement would include all those disparate
groups that saw law as a tool to promote the population's
health. The potential constituents of the movement included
legal counsel in public health agencies, partners in nonprofit organizations, private attorneys involved with public
health litigation, public health officials, legislators, and
academics in schools of law, medicine, and public health.
All these groups had been working on matters of population health, but rarely, if ever, came together to share ideas
and strategize on their agendas. Jim Curran, Dean of the
Rollins School of Public Health at Emory University, later
called this idea a "Public Health Law Collaborative."
As Gene recently put it: "I had no idea when we sat
down on that sofa in the lobby of the Emory Conference
Center that things would go like they have. I owe most of
what has happened positively in my professional world in
the past 5 years to that which flowed out of that encounter.
Still much to be clone." Those were the words Gene used
in announcing his retirement after precisely a quarter of a
century of distinguished service to American public health.
This symposium issue of the Journalof Law>, Medicine
&Ethics is dedicated to the career of Gene W. Matthews.
The volume is appropriately titled: Emerging Issues in
Journalof Law, Medicine &Ethics,31 (2003): 476-481.
@ 2003 by the Amnerican Society of Law, Medicine & Ethics.

PopulationHealth: Nationaland GlobalPerspectives.
I am humbled in the face of such a giant figure and
such a gentle, wise man leaving his distinguished government service. Gene Matthews has meant everything to law
and population health-he founded the modern field,
nurtured it, and provided such profound leadership and
wisdom that I cannot begin to express his contribution in
words. His service at CDC will be sorely missed, but never
forgotten. As Gene leaves his government service and moves
his work to the private sector, he has the deep appreciation of everyone who cares about using law as a tool for
promoting the public's health.
Gene Matthews became the Legal Advisor to CDC in
1979-he was the only attorney at that time, but the HHS
Office of the General Counsel now has a staff of 24
attorneys serving CDC. He worked under 6 CDC Directors
and has contributed to some of the most important milestones in public health history. (I have repeatedly urged
Gene to write a book of contemporary history on the
subject, and I hope his retirement from CDC will now
allow him time to do that). He was in the room when the
CDC staff was informed about the first 4 cases of AIDS in
1981. He witnessed remarkable events in the growth of
CDC and public health, including the unfolding of the AIDS
epidemic, the establishment of the Superfund environmental
programs, the retooling of worker protective equipment,
the maturing of our nation's immunization programs, and
the implementation of tobacco prevention strategies. Since
September 11, 2001, he also witnessed the new era in
public health, as CDC has learned to handle such urgent
demands as the anthrax attacks, West Nile virus, smallpox
preparedness, SARS, and monkeypox.
I vividly recall Gene's last visit to Georgetown University Law Center in November, 2003, where he laid out a
vision for global governance of SARS. His eyes glittering
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with excitement, Gene drew a map suggesting a new order
of global governance based on David Fidler's brilliant work
published in this volume. Armed with Gene's wise counsel,
I left for Geneva the following week to talk about the World
Health Organization's International Health Regulations.
So what did hatch at that eventful meeting at the Emory
Conference Center in 1998? What is Gene's legacy? Gene,
along with several "zealots" at CDC (Richard A. Goodman,
Anthony D. Moulton and, more recently, Frederic Shaw
and Montrece M. Ransom just to name a few) launched
the Public Health Law Program within CDC's Public Health
Practice Program Office.1 The creation of the Public Health
Law Program was CDC's recognition of the indispensable
role that law has played in most of the great public health
accomplishments of the 2001 century, from smoking reduction to record-setting childhood vaccination rates. The
Program has actively advanced the field: hosting the world's
first conference on public health law, now an annual event;
initiating a grant program for empirical research on public
health law; and supporting two collaborating centers on
public health law-one on research and the other on
2
collaboration.
The Public Health Law Association (PHLA) was founded
at the CDC's annual meeting of public health law in the
summer of 2003. The Association is dedicated to the
promotion of healthy communities through dialogue, partnerships, education, and research in public health law.
Robert M. Pestronk, Cynthia Honssinger, and Montrece
Ransom offer a brief account of the PHLA in this volume.
The HHS Office of the General Counsel and the Public
Health Law Program at CDC have emphasized public health
law preparedness since the tragic events of September 11"t.
Indeed, on October 5', 2001, the day after the first reported
case of anthrax, Gene called me about the need for
emergency preparedness. He had the foresight to understand that the White House and Governors would insist on
strong emergency health powers in light of the attacks.
Public health law scholars, he argued, should provide the
tools for political leaders to make informed choices. During
that conversation, we devised a strategy to draft the Model
State Emergency Health Powers Act (MSEHPA) as a checklist which states could use to ensure adequate legal authority.
The Center for Law and the Public's Health at Georgetown
and Johns Hopkins wrote the MSEHPA with the guidance of
a broad group of advisers. Currently, 32 states and the
District of Columbia had passed bills or resolutions that in5
clude provisions from or closely related to the Act.
Many legislators lamented the absence of a model law
that could be used routinely by public health agencies,
without the need for a declaration of a public health emergency. The Institute of Medicine, in its landmark report on
The Futureof the Public'sHealth in the 21" Century,lent its
weight behind reform of antiquated public health laws to
make them more uniform and effective.4 At the end of

2003, the Robert Wood Johnson "Turning Point" National
Excellence Collaborative' launched such a model lawthe Model State Public Health Act (MSPHA). 6 This model
law provides a tool for states to revise their laws to comply
with modern public health mission, functions, and essential services. The MSPHA was written by James G. Hodge
Jr. and me with broad support from a nationally recognized advisory committee, chaired by Deb Erickson, and
comprising members from the major governmental and
non-governmental organizations in public health. A
condensed version of the MSPHA is reproduced in an
Appendix to this symposium, and the full Act is accessible
at: www.publichealthlaw.net/Resources/Modellaws.htm.
Similar public health law reform efforts are ongoing in Asia,7
Europe,8 and Australia,9 particularly in the aftermath of SARS.
A FnLD oF

ScHoAI-smp ON POPULATION HEALTH

The field of public health law and ethics needs a body of
scholarship advancing its theory and practice at the global
and national level. This JLME symposium, Emerging Issues
in Population Health: National and Global Perspectives,
offers the kind of rigorous and practical scholarship needed
to begin the conversation. It is the second such JME
symposium," this time seeking to highlight the population-based perspective in international and national contexts.
I have had the privilege of working with some of the most
highly regarded public health law scholars and practitioners in assembling the articles and commentaries in this
issue ofJZME. I offer thanks to my colleagues at the Center
for Law and the Public's Health, Lesley Stone and Lance
Gable, for helping to assemble this collection of essays.
The Symposium is divided into four parts, representing some of the most vital and intriguing issues in the field
today: Global Challenges in Population Health; International Trade and Health; National Challenges in Population
Health; Population-Based Surveillance and Research; and
Public Health Preparedness,' Practice, and Teaching. In introducing each Part, and the chapters contained therein, I
will give JLME readers a sense of the significance of the
problems raised and contemporary initiatives in each area.
Julie L. Gerberding and colleagues from the CDC offer
a characteristically thoughtful and dynamic Foreword for
the Symposium. Their discussion of the many activities in
public health law during the last year leave the reader with
a sense of great achievement and even greater challenges
for the future. In Julie Gerberding, America has one of the
most talented public health leaders in the world-a person
who has inspired and led with a steady hand.

PART

I: GLOBAL

CHALLENGES IN POPULATION HEALTH

This]MEsymposium leads with global challenges to population health. One can identify at least four major pathways
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to understanding global public health law and ethics that
have captured the attention of policy makers and scholars.
The first major pathway is ancient, constant and abiding
diseases that kill such as tuberculosis and malaria. Whether
based on false optimism or hubris, scientific leaders
predicted the decline of infectious disease as a major cause
of mortality in the later half of the 2 0h Century. Although
infectious diseases are lessening, they are still the greatest
cause of mortality globally. Indeed, old diseases have
re-emerged in more virulent form (e.g., multi-drug resistant
tuberculosis); diseases once endemic in the Third World
have arrived in the First World (e.g., West Nile virs and
monkeypox); new diseases have posed an overwhelming
burden on major regions of the globe (e.g., H1V/AIDS);
and new threats have brought us back to a pre-therapeutic
era, without vaccines or treatments (e.g., SARS).
The second pathway is intentional dispersal of pathogens. Bio-Warfare and bio-terrorism certainly are not new.
However, concerns about bioterrorism vastly increased in
the aftermath of September 1 1 h and the subsequent
anthrax attacks. Reports of bioterrorism capacities in rogue
states and among terrorist cells heightened awareness."
The looming threat of bioterrorism triggered government
action-new laws to ensure adequate emergency health
powers, new resources designated for bioterrorism
preparedness, and reinvigorated debates about the appropriate balance between public safety and civil liberties.
The third pathway is through war, civil unrest, failed
nation-states, and forced migration of populations. Numerous conflicts can be seen throughout the world today, which
raise powerful threats to health. This problem is not only
attributable to the tragic injuries and deaths caused by anrned
conflict itself. It is also attributable to the conditions of
conflict, which exact a toll of suffering, disease, and death
in the population. With armed conflict often comes
inadequate supplies of safe and nutritious food and
potable water; an unsanitary environment; lack of access to
vaccines, medicines and health care; and mass migrations
resulting in homelessness and exposure to the cold or heat.
These conditions lead to starvation and dehydration, infectious diseases, as well as sexual and physical exploitation.
The final pathway is the rise of chronic, non-infectious diseases which are attributable to tobacco, diet, a
sedentary lifestyle, and other behavioral causes of morbidity
and mortality. Chronic diseases (e.g., cardiovascular
disease, cancer and diabetes) are rising in importance particularly in developed countries. (The symposium addresses
the problem of chronic diseases in Part II).
The authors in this symposium deal with each of these
major pathways. David Fidler continues his penetrating
international public health law scholarship by focusing his
attentions on the recent SARS outbreaks. By examining
global governance structures such as the International
Health Regulations, Professor Fidler explores the inadequacy

of extant methods of controlling major infectious disease
outbreaks. He proposes a new way of thinking about
global governance of infectious disease that is not tied so
inflexibly to state sovereignty.
Nicole Gastineau and Paul Farmer have been pioneers
in humanitarian efforts to reduce the burden of disease in
the midst of conflict. Their advocacy has been both in
scholarship and on-the-ground service in resource-poor
countries. In this important article Gastineau and Farmer
examine the role and potential for humanitarian intervention in the context of violent conflict.
Victor W. Sidel and Barry S. Levy have been equally
prominent voices in thinking about war, terrorism, and
public health. They have reminded us not only about the
imperative of health service delivery to displaced and
excluded populations, but also about the ethical and legal
dimensions of measured responses by governments and
adherence to principles of freedom, respect for persons,
and toleration of groups.
Finally, my Commentary explores one question that
has pervaded scholarly and political discourse since
September 1II": To what extent should human rights be
limited to protect the community's health and safety? I
endeavor to demonstrate why this is an imprecise question-because human rights are concerned both with civil
and political entitlements (e.g., autonomy, privacy, and liberty) as well as social and economic rights (e.g., the right
to health). I offer several proposals for balancing individual
interests in freedom and collective interests in health:
necessity, effective means, proportionality, and fairness.
PART H: INTERNATIONAL TRADE AND HEALTH

Globalism has become a lightening rod for public health
activists. The international community appears fixated on
questions of free markets, with the advent of the World
Trade Organization and regional trade agreements such as
the North American Free Trade Agreement (NAFTA).
(Despite the rhetoric of free trade, one might note that the
United States has often pursued parochial national interests-e.g., President Bush's imposition of tariffs on Chinese
textiles). Those in the public health con-ununity, however,
often see globalism as a subterfuge for policies designed to
harm poor populations. They wony particularly about intellectual property norms making it harder to attain
access to affordable vaccines and medications in resourcepoor countries. The WHO, UNAIDS, and other international
health agencies are currently seeking innovative policies for
ensuring that intellectual property does not become an
insunnountable barrier to health care access. The WHO, for
example, has set a goal of providing antiretroviral drugs to 3
2
million HIV-infected people by 2005 (the "3 by 5"program).'
In Africa, just 1% of HIV-infected people--50,000 out of 4.1
3
million who need it-have access to treatment.'
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The authors in this part of the symposium address this
issue. M. Gregg Bloche, a leader in health policy scholarship, and Elizabeth Jungman examine the political and legal
aspects of the world trade system and their relationship to
health. They focus on a problem that has captured the
attention of international health and trade agenciesaccess to antiretroviral medications for treating persons
living with HIV/AIDS.
Jason Sapsin and colleagues from the Johns Hopkins
Bloomberg School of Public Health continue this exploration.
The authors review the direct public health effects of intemational trade norms and examine policy structures to promote
effective public health advocacy in trade discussions.

PA"T

mI: NATIONAL CHALLENGES iN PoPuLAnoN

HEALTH

America is facing particular vexing health problems.
Although infectious diseases continue to be important, the
leading causes of death in the United States today are heart
disease, cancer, cerebrovascular diseases (including stroke),
chronic lower respiratory diseases (such as asthma,
bronchitis, and emphysema), and unintentional injuries.
These chronic health conditions are often associated with
behavior and lifestyle, which makes public health interventions particularly controversial. Based on the success
of tobacco policies, public health advocates are considering taxation, regulation, and tort litigation to address such
issues as obesity and firearm violence.
Wendy Perdue, Lesley Stone, and I at the Georgetown
University Law Center bring to bear historical perspective,
empirical evidence, and theoretical argumentation to show
how changes in the built environment could benefit the
public's health. Wendy Perdue is not only a law professor
but serves on the Planning Board for Montgomery County,
Maryland where she has political and practical experience
with the intersection of city planning and health. Here, she
begins an exploration of the role of law in altering the built
environment.
Jon Vemick at the Johns Hopkins Bloomberg School
of Public Health is one of the leading national figures in
gun control and injury prevention. Prof. Vernick and
colleagues explore new technologies to detect concealed
weapons. In a fascinating article, they pursue the idea of
scanning persons to detect firearms-an issue that is fraught
with controversy for civil libertarians and constitutional law
scholars.
Cynthia Schneider and Michael McDonald have been
working with Congress and the Bush Administration on
bioterrorism preparedness. In this article, they examine the
smallpox vaccination campaign. Although President Bush
planned to vaccinate some 500,000 health care workers,
only around 38,000 have actually received the vaccination.
Schneider and McDonald ask whether the U.S. smallpox
campaign was appropriately planned and how it could be

used as a lesson for future preparedness.
Preparedness for population health emergencies, of
course, is not limited to public health agencies at the state and
local level. The health care system plays a critically important
role, particularly hospitals, which may have to bear the brunt
of caring for sick or injured people. Sara Rosenbaum and
Brian Kamoie, nationally respected leaders in health care policy,
examine the Emergency Medical Treatment and Active Labor
Act (EMTALA). They point out the implications of EMTALA
for public health policy and practice.
The section on National Challenges ends with a
commentary by Daniel M. Fox, President of the Milbank
Memorial Fund and highly regarded scholar. Fox has an
enduring interest in the intersection of law, policy, and
politics. He offers the telling observation that the new
politics in the United States is connecting areas of policy
that, because they have had separate histories, are governed
by distinct, usually uncoordinated, laws and regulations.

PART IV PoPUIAnoN - BASED
SuRvEaiANCE AND RESEARCH

This section is dedicated to public health surveillance and
research, which is at the core of population-based science
and policy. Amy L. Fairchild writes the lead article for this
section, where she introduces readers to the concepts of
population-based surveillance and research. She seeks to
define the different, but related, ideas behind surveillance
and research, offering cogent historical explanations. The
distinction between surveillance and research is quite
important. If an undertaking is viewed as surveillance, then
the state is acting within its plenary police powers. Public
health surveillance is a quintessential form of public health
activity, and is subject to few external restraints. Public
health research, however, is most likely governed by the
Common Rule-a set of regulations designed to provide
clear limits on human subject research conducted with
federal dollars. These limits, notably, include examination
by an Institutional Review Board (IRB). A controversy has
swirled in recent years as to whether activities of state
public health agencies should be categorized as surveillance or research.
Fairchild, James Colgrove, and Ronald Bayer at the
Mailman School of Public Health at Columbia University
examine the myth of "exceptionalism" in Sexually
Transmitted Disease (STD) policy. Professor Bayer famously
characterized HIV/AIDS as an "exceptional" disease that
was not treated like other communicable diseases. In this
paper, the group from Columbia explore whether the same
arguments of "exceptionalism" could be made with respect
to all STDs. Currently, Ron Bayer, Amy Fairchild and I are
working on a set of ethical guidelines for public health
surveillance with the help of the CDC.
Scott Burris and colleagues write the following two
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articles. Burris, a celebrated thinker on public health law
and policy, returns to the questions raised by Fairchild and
colleagues concerning the distinction between public health
research and practice. He makes the innovative, albeit
controversial, argument that public health agencies should
be exempted from the Common Rule system. Burris and
colleagues suggest that state law (as it exists or in a
reformed capacity) could provide the safeguards required.
The article by James G. Hodge concludes Part IV.
Professor Hodge, Deputy Director of the Center for Law
and the Public's Health at Georgetown and Johns Hopkins,
has long been one of the nation's premier thinkers on
public health privacy. In this article, Hodge and colleagues
from the CDC examine the inevitable tensions between
the need for population-based data and the protection of
personal privacy.

readers. What is needed is for talented individuals to begin
teaching, scholarship, and practice in population-based law
and ethics. The ultimate goal is to use the law as a tool to
assure the conditions in which people can be healthier
and safer.
THE ILEGACy OF PuRLiC H

LTH

LAw REFORM AND LITIGATION

At a recent meeting of the Institute of Medicine's Board on
Health Promotion and Disease Prevention, Jim Curran made
a telling comment, particularly coming from someone with
vast experience in the field. He observed that history would
show that public health law reform and litigation would
be greatest public health legacy of our generation. That, in
many ways, is the legacy of Gene W. Matthews and, as
Gene so aptly put it, "there is still much to be done."

PART V PUBLIC HEALTH LAW: PREPAREDNESS,
PRAcncE, AND TEACHING

REFERENCEs

Part V in this symposium focuses on preparedness, practice,
and teaching in public health law. The CDC's Public Health
Law Program has emphasized the practical implications of
public health law. In the lead article for Part V, Anthony D.
Moulton and colleagues examine the idea of public health
preparedness. This article articulates public health preparedness as a goal and offers a conceptual framework.
In the following article Richard A. Goodman and
colleagues examine the intersection between public health
and criminal investigations. Goodman coined the term
"forensic epidemiology" and has developed coursework
for public health and law enforcement officials. This initiative is important because it facilitates coordination between
two traditionally separate institutions--law enforcement and
public health. Both are necessary to protect the public's
health and safety.
Wendy E. Parmet and Anthony Robbins, two dedicated public health scholars, have led the effort to expand
teaching of public health law in schools of law, medicine,
and public health. In this article, they tackle the particularly difficult problem of introducing population health into
the curricula of law schools. They argue that an engaging
scholarship that relies on the population perspective can
stimulate the integration of public health into core law
school classes.
Finally, Robert M. Pestronk, Cynthia Honssinger, and
Montrece Ransom present a brief news report about the
formation of the Public Health Law Association (PHLA).
The PHLA is a new non-profit organization designed to bring
together those interested in using the law to promote the
population's health. The PHLA symbolizes the resurgence
of public health law as a field with academic and practical
importance in national and international contexts.
I hope that the pages of this Symposium will inspire
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